Log in to save to my catalogue

Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy

Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11509085

Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy

About this item

Full title

Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy

Author / Creator

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2024-10, Vol.25 (20), p.11293

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Geldanamycin, an
-macrolide composed of a rigid benzoquinone ring and an aliphatic
-bridge, was isolated from
. Geldanamycin is a potent heat shock protein inhibitor with remarkable antiproliferative activity. However, it shows pronounced hepatotoxicity in animal models and unfavorable pharmacokinetic properties. Four geldanamycin analogs...

Alternative Titles

Full title

Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11509085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11509085

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms252011293

How to access this item